SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs Study Watch with Irregular Pulse Monitor (Home)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

Study Watch with Irregular Pulse Monitor (Home)

by Verily Life Sciences LLC

AI Verdict

Tool A is designed for point-of-care clinical decision support, assisting physicians in diagnosing heart murmurs through acoustic analysis of heart sounds. In contrast, Tool B is a wearable device focused on continuous physiological data collection, including ECG and irregular pulse monitoring for conditions like AFib, primarily for remote monitoring and clinical research. While both utilize AI in cardiology, they address different diagnostic and monitoring needs with distinct data acquisition methods and use cases.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI if you are a physician requiring immediate, AI-powered diagnostic assistance at the point of care to differentiate between physiological and pathological heart murmurs. This tool is ideal for enhancing the accuracy of your auscultation findings and complementing your clinical assessment of heart sounds in real-time.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose Study Watch with Irregular Pulse Monitor (Home) if…

Choose the Verily Study Watch if you need a prescription-only wearable for unobtrusive, continuous remote monitoring of physiological data, including irregular pulse for AFib detection, over an extended period. This device is well-suited for clinical research or for patients requiring long-term data collection in a home setting.

View Study Watch with Irregular Pulse Monitor (Home) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	Study Watch with Irregular Pulse Monitor (Home)
Pricing	Contact for pricing	Contact for pricing
Deployment	Hosted server environment (Linux OS) with a mobile application interface	Wearable device with cloud-based data processing.
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Study Watch with Irregular Pulse Monitor (Home)

Tool B, the Verily Study Watch, is designed as an unobtrusive wearable for continuous physiological data collection, making it highly usable for patients in a home setting. Tool A, SensiCardiac Mobi, is a mobile application requiring active physician interaction with an electronic stethoscope, which represents a different type of usability for a clinical workflow rather than passive patient monitoring.

Clinical Value

Study Watch with Irregular Pulse Monitor (Home)

Both tools are FDA-cleared and offer significant clinical value. However, Tool B's continuous, unobtrusive monitoring for irregular pulse (AFib detection) and other physiological data offers broad utility for early detection and long-term management, potentially preventing serious events like strokes. Tool A provides decision support for heart murmur diagnosis, which is also critical but more focused on a specific diagnostic moment.

Pricing & Value

Tie

Neither tool provides publicly available pricing information, stating 'contact for pricing.' Without transparent pricing details for either product, it is impossible to conduct a meaningful comparison of their value propositions.

Enterprise Readiness

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Tool A explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA) without any reported issues. While Tool B also claims HIPAA compliance and BAA availability, there is a reported lawsuit alleging HIPAA breaches in its past operations, which introduces a significant risk factor for enterprise adoption and trust.

Innovation

Study Watch with Irregular Pulse Monitor (Home)

Tool B, the Verily Study Watch, demonstrates higher innovation through its multi-sensor wearable platform, offering unobtrusive, continuous physiological and environmental data collection with long battery life, on-device encryption, and cloud-based machine learning analytics. Tool A's AI-powered heart murmur diagnosis is innovative in applying AI to auscultation, but Tool B's comprehensive approach to remote monitoring and data acquisition represents a broader technological advancement.

Support & Docs

Tie

The provided structured facts do not contain any information regarding the availability or quality of support and documentation for either Tool A or Tool B. Public web searches also do not readily provide specific details on support portals or documentation libraries for general users for either product, making a comparative assessment impossible.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	Study Watch with Irregular Pulse Monitor (Home)
Tool Name	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	Study Watch with Irregular Pulse Monitor (Home)
Primary Function	Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds.	Prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring.
Company	DIACOUSTIC MEDICAL DEVICES (PTY)	Verily Life Sciences LLC
Core Diagnostic/Monitoring Capability	Analyzes heart sounds using the Sensi Diagnostic Heart Murmur Algorithm; Distinguishes between normal/physiological and pathological heart murmurs; Identifies S1, S2, and suspected murmurs.	On-demand single-channel ECG measurement; Irregular pulse monitoring for atrial fibrillation (AFib) detection.
Device Type / Data Capture Method	Mobile application for data capture and display (e.g., iPhone 4S or later); Requires a compatible electronic stethoscope (user-provided).	Wearable device with multiple physiological sensors (heart rate, electrodermal activity, inertial movements); Environmental sensors.

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and Study Watch with Irregular Pulse Monitor (Home).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into a physician's existing clinical workflow for patient assessment and diagnosis?

SensiCardiac Mobi integrates into a physician's immediate diagnostic workflow during patient auscultation, providing real-time decision support for heart murmur differentiation. The Verily Study Watch, conversely, is designed for remote, unobtrusive physiological data collection from patients, primarily for irregular pulse monitoring and AFib detection over time.

What level of integration can be expected with existing Electronic Health Record (EHR) systems for each tool?

SensiCardiac Mobi records acoustic heart signals and provides analysis via a mobile application, suggesting data export capabilities that would need to be integrated with an EHR. The Verily Study Watch utilizes cloud-based data processing, which typically allows for more robust integration options with EHR systems for automated data transfer and population health management.

How do the diagnostic capabilities and accuracy of these tools compare for their respective clinical applications?

SensiCardiac Mobi focuses on the diagnostic accuracy of heart murmur differentiation using AI-powered acoustic analysis, aiding in the identification of pathological sounds at the point of care. The Verily Study Watch's accuracy is centered on irregular pulse monitoring for atrial fibrillation detection and on-demand single-channel ECG measurements, providing continuous or intermittent data for rhythm analysis.

Beyond the listed specialties, what specific clinical scenarios or patient populations are each tool best suited for?

SensiCardiac Mobi is particularly well-suited for primary care physicians, internal medicine, and pediatricians needing immediate assistance in screening and differentiating heart murmurs during routine examinations. The Verily Study Watch is ideal for cardiologists and family physicians managing patients requiring continuous or intermittent monitoring for irregular heart rhythms, especially for AFib detection in at-risk populations or for clinical research.

What is the expected learning curve for physicians and their staff, and how quickly can a practice expect to see clinical value from each tool?

SensiCardiac Mobi, as a mobile application assisting with an existing auscultation workflow, likely has a relatively low learning curve for physicians, offering immediate diagnostic support and time-to-value at the point of care. The Verily Study Watch, being a patient-worn device with cloud-based analytics, may involve a slightly steeper learning curve for patient onboarding and data interpretation, with value realized through ongoing remote monitoring and trend analysis over time.

What factors should be considered for deploying these tools across multiple clinical sites or a larger healthcare system?

For SensiCardiac Mobi, multi-site rollout would involve ensuring compatible electronic stethoscopes and mobile devices are available and configured at each location, along with consistent physician training on the application. The Verily Study Watch would require considerations for scalable distribution of prescription-only wearable devices to patients across multiple sites, managing patient onboarding, and ensuring consistent access and interpretation of cloud-based data across the healthcare system.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION or Study Watch with Irregular Pulse Monitor (Home)

Backers

Who funded each tool's parent company.